Compositions and methods for the improved production and delivery of RNA by efficient transcription termination

US9814243B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9814243-B2
Application numberUS-201414901003-A
CountryUS
Kind codeB2
Filing dateMar 13, 2014
Priority dateMar 15, 2013
Publication dateNov 14, 2017
Grant dateNov 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.

First claim

Opening claim text (preview).

What is claimed is: 1. A transcriptional terminator comprising a nucleic acid sequence that comprises a rrn BT2 transcription terminator sequence, a first PET transcription terminator sequence, a PTH transcription terminator sequence, and a second PET transcription terminator sequence, wherein the rrn BT2 transcription terminator sequence, the first and second PET transcription terminator sequences, and the PTH terminator sequence comprise hairpins. 2. The transcriptional terminator of claim 1 , wherein the hairpins are separated by a spacer region comprising 10 or fewer nucleotides. 3. The transcriptional terminator of claim 1 , wherein the hairpins comprise a stem region with fewer than 3 unpaired nucleotides. 4. The transcriptional terminator of claim 3 , wherein the hairpins comprise a stem region with no unpaired nucleotides. 5. The transcriptional terminator of claim 1 , wherein the nucleic acid sequence is selected from the group consisting of SEQ ID NOs: 18 and 21. 6. The transcriptional terminator of claim 1 , wherein the rrnBT2 terminator sequence comprises SEQ ID NO: 9. 7. The transcriptional terminator of claim 1 , wherein the first, second, or both PET terminator sequences comprise SEQ ID NOs: 5 or 13. 8. The transcriptional terminator of claim 1 , wherein the PTH terminator sequence comprises SEQ ID NO: 7.

Assignees

Inventors

Classifications

  • Expression systems using regulatory sequences derived from the lac-operon · CPC title

  • General methods for enhancing the expression · CPC title

  • Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

  • Processes for modifying phenotypes {, e.g. symbiosis with bacteria} (A01H4/00 takes precedence) · CPC title

  • A01N63/02Primary

    Human Necessities · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9814243B2 cover?
Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The desc…
Who is the assignee on this patent?
Monsanto Technology Llc
What technology area does this patent fall under?
Primary CPC classification A01N63/02. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).